Increase in mRNA concentrations of pituitary receptors for growth hormone-releasing hormone and growth hormone secretagogues after neonatal monosodium glutamate treatment

Journal of Neuroendocrinology

Volumn 12, Issue 4, 2000, Pages 335-341

  Kovacs, ^a,d   Kineman, ^c   Schally, ^a,b   Flerko, ^d   Frohman, ^c  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE SODIUM; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR RECEPTOR; JI 38; MESSENGER RNA; PROTEIN; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HYPOPHYSIS; LIVER; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; DNA PRIMERS; GENE EXPRESSION REGULATION; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; LIVER; PITUITARY GLAND; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE; RECEPTORS, PITUITARY HORMONE-REGULATING HORMONE; RECEPTORS, SOMATOTROPIN; RNA, MESSENGER; SODIUM GLUTAMATE;

EID: 0034060312     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.2000.00458.x     Document Type: Article

References (53)

1. Clark RG, Robinson ICAF. Growth induced by pulsatile infusion of an amidated fragment of human growth hormone releasing factor in normal and GHRF-deficient rats. Nature 1985; 314: 281-283.
2. Thorner MO, Reschke J, Chitwood J, Rogol AD, Furlanetto R, Rivier J, Vale W, Blizzard RM. Acceleration of growth in two children treated with human growth hormone-releasing factor. N Engl J Med 1985; 312: 4-9.
3. Gelato MC, Ross JL, Malozowsky S, Pescovitz OH, Skerda M, Cassoria F, Loriaux DL, Merriam GR. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency. J Clin Endocrinol Metab 1985; 61: 444-450.
4. Gelato MC, Oldfield E, Loriaux DL, Merriam GR. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion. J Clin Endocrinol Metab 1990; 71: 585-590.
5. Brain CE, Hindmarsh PC, Brook CG. Continuous subcutaneous GH-RH (1-29)NH2 promotes growth over 1 year in short, slowly growing children. Clin Endocrinol 1990; 32: 153-163.
6. Kovacs M, Fancsik A, Mezo I, Teplan I, Flerko B. Effects of continuous and repetitive administration of a potent analog of GH-RH(1-30), NH2 on the GH release in rat. Neuroendocrinology 1994; 59: 371-379.
7. Mayo KE, Godfrey PA, Suhr ST, Kulik DJ, Rahal JO. Growth hormone-releasing hormone. Synthesis and Signaling. Rec Prog Horm Res 1995; 50: 35-73.
8. Olney JW. Neurotoxicity of excitatory amino acids. In: McGeer EG, Olney JW, McGeer PL. eds. Kainic Acid as a Tool in Neurobiology. New York; Raven Press., 1978: 95-121.
9. Acs Z, Antoni FA, Makara GB. Corticoliberin and somatoliberin activity in the pituitary stalk median eminence of rats after neonatal treatment with monosodium glutamate. J Endocrinol 1982; 93: 239-245.
10. Bloch B, Ling N, Benoit R, Wehrenberg WB, Guillemin R. Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence. Nature 1984; 307: 272-273.
11. 2 on the GH release in rats treated with monosodium glutamate. J Neuroendocrinol 1995; 7: 703-712.
12. Mailer D, Underwood LE, Marti JB, Koenig JI. Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats. Endocrinology 1991; 128: 1100-1106.
13. Kovacs M, Halmos G, Groot K, Izdebski J, Schally AV. Chronic administration of a new potent agonist of growth hormone-releasing hormone induces compensatory linear growth in growth hormone-deficient rats: mechanism of action. Neuroendocrinology 1996; 64: 169-176.
14. Howard AD, Feighner SD, Cullt DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J. Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong S-S, Chaung L-YP, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghi DJS, Dean DC, Melillo DG, Patchett AA, Nargund RP, Griffin PR, DeMartino JA, Gupta SK, Schaefler JM, Smith RG, Van der Ploeg LHT. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996; 273: 974-977.
15. Izdebski J, Pinski J, Horvath JE, Halmos G, Groot K, Schally AV. Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone. Proc Natl Acad Sci USA 1995; 92: 4872-4876.
16. Kovacs M, Mezo I, Teplan I, Hollosi M, Kajtar J, Flerko B. New GABA-containing analogues of hGH-RH (1-30)-amide: detailed in vivo biological examinations. J Endocrinol Invest 1993; 16: 799-805.
17. Breier BH, Gallaher BW, Gluckman PD. Radioimmunoassay for insulin-like growth faclor-1: solutions to some potential problems and pitfalls. J Endocrinol 1991; 128: 347-357.
18. Daughaday WH, Mariz IK, Blethen SL. Inhibition of access of bound somatomedin to membrane receptor and immunoglobulin sites: a comparison of radio-receptor and radioimmunoassay of somatomedin in native and acid-ethanol extracted serum. J Clin Endocrinol Metab 1980; 51: 781-788.
19. Mayo KE, Godfrey PA, Suhr ST, Kulik DJ, Rahal JO. Growth hormone-releasing hormone: synthesis and signaling. Recent Prog Horm Res 1995; 50: 35-73.
20. Aleppo G, Moska SF, De Grandis PA, Kineman RD, Frohman LA. Homologous down-regulation of growth hormone-releasing hormone receptor messenger ribonucleic acid levels. Endocrinology 1997; 138: 1058-1065.
21. McKee KK, Palyha OC, Feighner SD, Hreniuk DL, Tan CP, Phillips MS, Smith RG, Van der Ploeg LH, Howard AD. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. Mol Endocrinol 1997; 11: 415-423.
22. Kamegai J, Wakabayashi I, Miyamoto K, Unterman TG, Kineman RD, Frohman LA. Growth hormone (GH) dependent regulation of pituitary GH secretagogue receptor receptor (GHS-R) mRNA levels in in sponteneous dwarf rat. Neuroendocrinology 1998; 68: 312-318.
23. Roberts CT Jr, Lasky SR, Lowe WL Jr, Seaman WT, LeRoith D. Molecular cloning of rat insulin-like growth factor 1 complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol Endocrinol 1987; 1: 243-248.
24. Simson EL, Gold RM, Standish LJ, Pellett PL. Axon-sparing brain lesioning technique: the use of monosodium-L-glutamate and other amino-acids. Science 1977; 198: 515-517.
25. Slama A, Bluet-Pajot MT, Mounier F, Videau C, Kordon C, Epelbaum J. Effects of neonatal administration of octreotide, a long-lasting somatostatin analogue, on growth hormone regulation in the adult rat. Neuroendocrinology 1996; 63: 173-180.
26. Sasaki F, Kawai T, Ohta M. Immunohistochemical evidence of neurons with GHRH or LHRH in the arcuate nucleus of male mice and their possible role in the postnatal development of adenohypophysial cells. Anat Rec 1994; 240: 255-260.
27. Corder R, Saudan P, Mazlan M, McLean C, Gaillard RC. Depletion of hypothalamic growth hormone-releasing hormone by neonatal monosodium glutamate treatment reveals an inhibitory effect of betamethasone on growth hormone secretion in adult rats. Neuroendocrinology 1990; 51: 85-92.
28. Wakabayashi I, Hatano H, Minami S, Tonegawa Y, Akira S, Sugihara H, Ling NC. Effects of neonatal administration of monosodium glutamate on plasma growth hormone (GH) response to GH-releasing factor in adult male and female rats. Brain Res 1986; 372: 361-365.
29. Clemens JA, Roush ME, Fuller RW, Shaar CJ. Changes in luteinizing hormone and prolactin control mechanisms produced by glutamate lesions of the arcuate nucleus. Endocrinology 1978; 103: 1304-1312.
30. Sridaran R, Rodrigez-Sierra JF, Blake CA. Effects of hypothalamic arcuate nucleus lesions on pulsatile luteinizing hormone concentrations in ovariectomized rats. Proc Soc Exp Biol Med 1981; 168: 38-44.
31. Nemeroff CB, Lamertiniere CA, Mason GA, 31. Squibb RE, Hong SJ, Bondy SC. Marked reduction in gonadal steroid hormone levels in rats treated neonatally with monosodium L-glutamate: further evidence for disruption of hypothalamic-pituitary-gonadal axis regulation. Neuroendocrinology 1981; 33: 265-267.
32. Rodriguez-Sierra JF, Blaustein JD, Blake CA, Clough RW, Elias KA. A decrease of cytosol estrogen receptors in the hypothalamus as a result of treatment of neonatal rats with glutamate. Exp Brain Res 1982; 48: 272-278.
33. Krieger DT, Liotta AS, Nicholsen G, Kizer JS. Brain ACTH and endorphin reduced in rats with monosodium glutamate-induced arcuate nucleus lesions. Nature 1979; 278: 562-563.
34. Millard WJ, Martin JB, JrAudet J, Sager SM, Martin JB. Evidence that reduced growth hormone secretion observed in monosodium glutamate-treated rats is the result of a deficiency in growth hormone-releasing factor. Endocrinology 1982; 110: 540-550.
35. Dada MO, Campbell GT, Blake C. Effects of neonatal administration of monosodium glutamate on somatotropes and growth hormone secretion in prepubertal male and female rats. Endocrinology 1984; 115: 996-1003.
36. Arce V, Garcia Barros M, Vara E, Lima L, Tresguerres JA, Devesa J. Clonidine potentiates the growth hormone response to a growth hormone releasing hormone challenge in hypothalamic growth hormone releasing hormone deficient rats. Neuroendocrinology 1995; 61: 552-558.
37. Ling SC, Esch F, Bohlen P, Brazeau P, Wehrenberg WB, Rosenfeld MG. Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature 1993; 364: 208-213.
38. Barinaga M, Bilezikjian LM, Vale MW, Rosenfeld MG, Evans RM. Independent effects of growth hormone releasing factor on growth hormone release and gene transcription. Nature 1985; 314: 279-281.
39. Lowe WL, Lasky SR, LeRoith D, Roberts CT Jr. Distribution and regulation of rat insulin-like growth factor I messenger ribonucleic acids encoding alternative carboxyterminal E-peptides: evidence for differential processing and regulation in liver. Mol Endocrinol 1988; 2: 528-535.
40. Kubota A, Nakagawa Y, Igarashi Y. Studies of gene expression in liver of insulin-like growth factor (IGF) -I, IGF binding protein-3 and growth hormone (GH) receptor/GH binding protein in rats treated neonatally with monosodium glutamate. Horm Metab Res 1994; 26: 497-503.
41. Zhang J, Whitehead RE Jr, Underwood LE. Effect of fasting on insulin-like growth factor (IGK) -1A and IGK-IB messenger ribonucleic acids and prehormones in rat liver. Endocrinology 1977; 138: 3112-3118.
42. Lund PK. Insulin-like growth factors: gene structure and regulation. In: Kostyo JL. eds. Handbook of Physiology Section 7 the Endocrine System, Vol. V Hormonal Control of Growth. Oxford University Press: New York, 1999: 537-571.
43. Lopes MB, Gaylinn BD, Thorner MO, Stoler MH. Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors. Am J Pathol 1997; 150: 1885-1891.
44. Smith RG, Van der Ploeg HT, Howard AD, Feighner SD, Cheng K, Mickey GJ, Wyratt MJ. Peptidomimetic regulation of growth hormone secretion. Endocr Rev 1997; 18: 621-545.
45. Kamegai J, Unterman TG, Frohman LA, Kineman RD. Hypothalamic/ pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid. Endocrinology 1998; 139: 3554-3560.
46. Takeutchi T, Suzuki H, Sakurai S, Nagami H, Okuma S, Ishikawa H. Molecular mechanism of growth hormone (GH) deficiency in the spontaneous dwarf rat: detection of abnormal splicing of GH messenger ribonucleic acid by the polymerase chain reaction. Endocrinology 1990; 126: 31-38.
47. Korytko AI, Cuttler L. IGF-I and IGK-II regulation of GHRH-receptor gene expression in the perinatal and adult pituitary. Program of the 80th Annual Meeting of the Endocrine Society. New Orleans, LA, 1998: 297.
48. Larsen PJ, Mikkelsen JD, Jessop D, Lightman SL, Chowdrey HS. Neonatal monosodium glutamate treatment alters both the activity and the sensitivity of the rat hypothalamic-pituitary-adrenal axis. J Endocrinol 1988; 141: 497-503.
49. Dolnikoff MS, Kater CE, Egami M, de Andrade IS, Marmo MR. Neonatal treatment with monosodium glutamate increases plasma corticosterone in the rat. Neuroendocrinology 1988; 48: 645-649.
50. Tamaki M, Sato M, Matsubara S, Wada Y, Takahara J. Dexamethasone increases growth hormone (GH)-releasing hormone (GRH) receptor mRNA levels in cultured rat anterior pituitary cells. J Neuroendocrinol 1996; 8: 475-480.
51. Miller TL, Mayo KE. Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression. Endocrinology 1997; 138: 2458-2465.
52. Tamura H, Kamegai J, Sugihara H, Kineman RD, Frohman LA, Wakabayashi I. Glucocorticoids regulate pituitary growth hormone secretagogue receptor (GHS-R) gene expression. J Neuroendocrinol in press.
53. Isgaard J, Carlsson L, Isaksson OG, Jansson JO. Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion. Endocrinology 1988; 123: 2605-2610.